First Light Asset Management’s Cytokinetics CYTK Stock Holding History

First Light Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-218,792	Closed	-$1.47M	–	63
2015 Q2	$1.47M	Buy	218,792 +19,778	+10%	+$130K	0.69%	37
2015 Q1	$1.35M	Buy	199,014 +19,825	+11%	+$148K	0.69%	37
2014 Q4	$1.44M	Buy	179,189 +14,143	+9%	+$60.7K	0.81%	38
2014 Q3	$581K	Buy	165,046 +3,475	+2%	+$14.6K	0.4%	38
2014 Q2	$772K	Buy	161,571 +8,233	+5%	+$50.2K	0.52%	42
2014 Q1	$1.46M	Buy	153,338 +22,887	+18%	+$207K	1.03%	32
2013 Q4	$848K	Buy	+130,451	New	+$857K	0.72%	40

Other funds holding CYTK

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

First Light Asset Management's CYTK Position: Q3 2015 in Review

First Light Asset Management sold out of Cytokinetics (CYTK) in Q3 2015, closing a stake of 218,792 shares — an estimated $1.47M sold.

First Light Asset Management first reported a position in CYTK in Q4 2013 and held it in 7 quarters. The position peaked at $1.47M in Q2 2015. 105 funds tracked by Wall St. Rank hold CYTK as of Q3 2015.

First Light Asset Management reported no remaining Cytokinetics position as of Q3 2015 after selling out during the quarter.
First Light Asset Management sold 218,792 Cytokinetics shares in Q3 2015, an estimated $1.47M.
First Light Asset Management first reported a position in Cytokinetics in Q4 2013 and held it in 7 quarters.
First Light Asset Management's Cytokinetics position peaked at $1.47M in Q2 2015.
105 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2015.

Based on First Light Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.